Further examination revealed that RES inhibited CH processes by activating AMP-AMPK through upregulating liver kinase B1 (LKB1), the activating kinase of AMPK, leading to inhibition of p70S6K, eEF2, and NFAT signaling pathways (105). The gene discussed is STK11; the disease is cyclic hematopoiesis.